Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Functional Impact of Protein–RNA Variation in Clinical Cancer Analyses
Gali Arad,
Tamar Geiger
*
*
Corresponding author for this work
Protai Bio
Weizmann Institute of Science
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Functional Impact of Protein–RNA Variation in Clinical Cancer Analyses'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Data-centric
100%
Protein Level
100%
Protein Expression
100%
Phenotypic Outcome
100%
Cellular Processes
100%
Molecular Characterization
100%
Drug Target
100%
RNA Analysis
100%
Tumor
100%
Cell Behavior
100%
Expression Analysis
100%
Cancer Types
100%
MRNA Expression
100%
Proteomics
100%
Functional Impact
100%
Cancer mutations
100%
Protein Analysis
100%
Transcriptome Analysis
100%
Tumor Classification
100%
Unsupervised Clustering
100%
Cancer Study
100%
Patient-tailored Therapy
100%
Functional Pathways
100%
Large Amount of Data
100%
Drug Resistance Mechanisms
100%
Cancer Drivers
100%
Cancer Analysis
100%
Cancer Vulnerability
100%
Clinical Proteomic Tumor Analysis Consortium
100%
Tumor Characterization
100%
Resistance Biomarkers
100%
Biochemistry, Genetics and Molecular Biology
RNA
100%
Proteomics
100%
Drug Resistance
50%
Messenger RNA
50%
Maturation
50%
Cell Function
50%
Gene Expression Profiling
50%
Protein Characterization
50%
Expression Analysis
50%
Tumor Classification
50%